This is a cross-sectional, multi-center, multi-national, epidemiological study to estimate the prevalence of anti-JCV antibody in MS participants. This study will provide an estimate of the prevalence of anti-JCV antibody in the MS population and will investigate inter-country differences.
The objective of the study is to estimate the prevalence of anti-JCV antibodies in multiple sclerosis (MS) participants.